CAPPELLO, Paola
 Distribuzione geografica
Continente #
NA - Nord America 8.581
EU - Europa 5.559
AS - Asia 4.444
AF - Africa 149
OC - Oceania 94
SA - Sud America 71
Continente sconosciuto - Info sul continente non disponibili 10
Totale 18.908
Nazione #
US - Stati Uniti d'America 8.452
CN - Cina 2.693
IT - Italia 1.645
SE - Svezia 709
DE - Germania 545
IE - Irlanda 517
FR - Francia 365
TW - Taiwan 352
SG - Singapore 348
UA - Ucraina 328
AT - Austria 281
KR - Corea 263
GB - Regno Unito 250
FI - Finlandia 239
PL - Polonia 195
JP - Giappone 179
VN - Vietnam 142
HK - Hong Kong 129
DK - Danimarca 115
IN - India 115
SN - Senegal 113
CA - Canada 97
AU - Australia 87
TR - Turchia 86
BE - Belgio 62
NL - Olanda 53
ES - Italia 51
BR - Brasile 47
CH - Svizzera 44
RU - Federazione Russa 37
IR - Iran 28
MX - Messico 27
GR - Grecia 18
IL - Israele 15
RO - Romania 14
NO - Norvegia 13
HU - Ungheria 12
TH - Thailandia 12
UZ - Uzbekistan 12
PK - Pakistan 11
PT - Portogallo 11
CZ - Repubblica Ceca 10
EU - Europa 10
BY - Bielorussia 9
IQ - Iraq 9
MA - Marocco 9
ID - Indonesia 8
NG - Nigeria 8
EE - Estonia 7
EG - Egitto 7
LU - Lussemburgo 7
MO - Macao, regione amministrativa speciale della Cina 7
NZ - Nuova Zelanda 7
AR - Argentina 6
CL - Cile 6
LB - Libano 6
HR - Croazia 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
MY - Malesia 4
PR - Porto Rico 4
AL - Albania 3
LK - Sri Lanka 3
PE - Perù 3
PH - Filippine 3
RS - Serbia 3
SC - Seychelles 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CY - Cipro 2
DZ - Algeria 2
EC - Ecuador 2
MD - Moldavia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
BD - Bangladesh 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BZ - Belize 1
CO - Colombia 1
GH - Ghana 1
IM - Isola di Man 1
JO - Giordania 1
NP - Nepal 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
YE - Yemen 1
Totale 18.908
Città #
Chandler 1.210
Beijing 741
Houston 583
Fairfield 533
Dublin 516
Ann Arbor 461
Ashburn 374
Torino 320
Woodbridge 299
Vienna 277
Wilmington 267
Taipei 264
Nyköping 263
Dearborn 246
Shanghai 243
Jacksonville 236
Redwood City 236
Seattle 209
Guangzhou 198
Singapore 193
Cambridge 179
Villeurbanne 165
Medford 161
Warsaw 158
Turin 155
Pisa 153
Princeton 153
Los Angeles 130
Fremont 110
Milan 103
Nanjing 102
Dong Ket 96
Hangzhou 89
Rome 88
Wuhan 70
Boardman 69
Boston 69
Tokyo 63
Chengdu 60
Shenyang 50
New York 46
Washington 46
San Diego 45
Changsha 40
Zhengzhou 39
Brussels 38
Munich 36
Seoul 34
Changchun 32
Helsinki 31
Verona 31
Xian 31
Kunming 29
Norwalk 29
Tianjin 27
Hong Kong 26
Hebei 25
London 25
Paris 25
Chongqing 23
Phoenix 23
San Mateo 22
Toronto 22
Düsseldorf 20
Jinan 20
Chennai 19
Hefei 19
Heidelberg 19
Frankfurt am Main 18
Fuzhou 17
Melbourne 17
Nanchang 17
Detroit 16
Falls Church 16
Lanzhou 16
Polska 16
Seongnam 16
Ottawa 15
Silver Spring 15
Guiyang 14
Istanbul 14
Villadose 14
Farmington 13
Harbin 13
Mountain View 13
Omaha 13
Philadelphia 13
Portland 13
Santa Clara 13
Upper Marlboro 13
Central 12
Erlangen 12
Florence 12
Piemonte 12
Pittsburgh 12
Rochester 12
San Jose 12
Shenzhen 12
Asti 11
Bethesda 11
Totale 11.157
Nome #
Alpha-Enolase (ENO1), a potential target in novel immunotherapies 1.566
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 953
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 540
Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response. 433
Vaccination with ENO1 DNA Prolongs Survival of Genetically Engineered Mice with Pancreatic Cancer. 420
Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. 418
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 404
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells 398
Molecular and genetic bases of pancreatic cancer 376
Regulation of Langerhans cell functions in a hypoxic environment 322
Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mDCs: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. 293
The advanced glycation end-product Nϵ-carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention 288
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 266
CC-chemokine ligand 16 induces a novel maturation program in human immature monocyte-derived dendritic cells 237
CCL16 activates an angiogenic program in vascular endothelial cells 236
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 234
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 229
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest 217
Pancreatic cancer vaccine: a unique potential therapy 215
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 204
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis 204
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response 198
α-enolase: a promising therapeutic and diagnostic tumor target 196
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 194
Macrophage PI3Kγ drives pancreatic ductal adenocarcinoma progression 193
Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype 184
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 178
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 173
The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response 172
Next generation immunotherapy for pancreatic cancer: DNA vaccination is seeking new combo partners 167
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1 155
Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer 153
In pancreatic cancer chemotherapy increases anti-tumor responses to tumor associated antigens and potentiates DNA vaccination 141
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma 140
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer 139
Three are better than one: plasminogen receptors as cancer theranostic targets. 139
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 135
The hypoxic environment induces a migratory or a proinflammatory phenotype in DCs depending on their maturation stage. Identification of TREM-1 as a common hypoxia marker 134
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma associated antigen 132
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis. 131
Antibody and T cell response profiling of pancreatic cancer patients before and after chemotherapy reveals increased recognition of antigens suitable for immunotherapy 131
BLOCKADE OF SURFACE ALPHA-ENOLASE (ENO1) AS A NOVEL IMMUNOTHERAPEUTIC APPROACH IN PANCREATIC CANCER 130
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 129
Strigolactone analogs are promising antiviral agents against Herpesviruses 126
Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy 125
Activation of T cells against HER-2/neu+ by autologous dendritic cells loaded with rat HER-2/neu+ cells in the presence of CCL16 120
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 120
Endogenous glutamine decrease is associated with pancreatic cancer progression 114
Autoantibody signature in human ductal pancreatic adenocarcinoma 109
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 107
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 106
Next generation of cancer immunotherapy calls for combination 106
Activation of T cells against human HER-2/neu by autologous Dendritic Cells loaded with rat HER-2/neu+ cells in the presence of CCL16 105
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. 104
Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine Receptor-α1 99
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 97
Human dendritic cells differentiated in hypoxia down modulate antigen uptake and change their chemokine expression profile 97
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 97
CCL16, a powerful tool for monocyte-derived dendritic cell maturation 97
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice 96
Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial 96
AN ISOLATED MONOPHOSPHORYLATED PEPTIDE DERIVED FROM HUMAN ALPHA-ENOLASE USEFUL FOR DIAGNOSIS AND TREATMENT OF PANCREATIC ADENOCARCINOMA, ANTIBODIES DIRECTED AGAINST THE SAID MONOPHOSPHORYLATED PEPTIDE, AND USES THEREOF 94
The dark side of immunotherapy: pancreatic cancer 92
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 92
THE BLOCKADE OF PLASMINOGEN-ALPHA-ENOLASE INTERACTION INHIBITS THE INVASION OF PANCREATIC CANCER CELLS. 91
Abstract 4984: Chemotherapy induces a coordinate autoantibody and T-cell response against tumor-associated antigens in pancreatic cancer patients 89
Peptide monofosforilato isolato derivato dall'alfaenolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi 88
G PROTEIN COUPLED RECEPTORS MEDIATE FIBROBLAST CHEMOTAXIS INDUCED BY BRONCOALVEOLAR LAVAGE FLUID OF ARDS PATIENTS 88
Identification of chemotherapy-induced antigens suitable for immunotherapy in pancreatic cancer patients 88
Autoantibodies to the ectoenzyme a enolase, identify a pancreatic adenocarcinoma (PDA)-associated antigen that elicits both CD4 and CD8 T cell response 87
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 85
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 85
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer 85
Vaccino a DNA per l’uso nel trattamento profilattico o terapeutico dell’adenocarcinoma duttale pancreatico 85
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 84
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 83
Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. 82
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 82
Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma 82
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 81
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 80
IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine 80
Ventilatory Management During Normothermic Ex Vivo Lung Perfusion: Effects on Clinical Outcomes 79
Molecola perturbation of IFNγR2 internalization reinstates T cell sensitività to the IFNγ/STAT1 signaling pathway in vitro and in vivo. 5th 78
Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine/receptor expression profile 78
Soluble stroma-related biomarkers of pancreatic cancer 78
Apoptosis in the development of the mouse olfactory epithelium. 78
Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression. 77
IL17A CRITICALLY SHAPES THE TRANSCRIPTIONAL PROGRAM OF FIBROBLASTS IN PANCREATIC CANCER AND SWITCHES ON THEIR PRO-TUMORIGENIC FUNCTIONS 77
The ectoenzyme α-enolase, a pancreatic adenocarcinoma (PDAC)-associated antigen, elicits both in vitro and in vivo T cell responses 76
Hypoxia inhibits antigen up-take by immature human dendritic cells 75
CCL16 chemokine optimizes tumor antigen presentation by inducing a new human dendritic cell maturation stage. “9th 74
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 74
Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression 74
Metodo per indurre la maturazione delle cellule dendritiche 71
α-enolase ectoenzyme, a pancreatic adenocarcinoma (PDAC)-associated antigen, elicits both in vitro and in vivo T cell responses 71
Survival and Migration of Human Dendritic Cells AreRegulated by an IFN-alpha-Inducible Axl/Gas6 Pathway 71
Discovery of Targets for Cancer Immunoprevention 70
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 69
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis (SERPA) 69
Totale 16.960
Categoria #
all - tutte 46.584
article - articoli 0
book - libri 0
conference - conferenze 10.925
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.062 0 174 236 352 224 575 307 222 320 253 215 184
2020/20212.637 196 154 203 149 288 254 210 160 273 218 190 342
2021/20222.633 157 160 165 261 168 149 215 158 79 190 498 433
2022/20233.466 268 295 80 403 328 776 227 310 389 123 137 130
2023/20242.435 214 246 140 102 196 222 101 119 26 125 444 500
2024/2025574 345 229 0 0 0 0 0 0 0 0 0 0
Totale 19.503